Nifty Pharma Today: Index Ends 0.04% Lower on 2 September

Updated: 2 Sept 2026 • 4:16 pm

Posted by:

Nifty Pharma Today: Index Ends 0.04% Lower on 2 September

Quick sector takeaways

Nifty Pharma ended at 26,780.70, down 11.95 points or 0.04% from its previous close of 26,792.65.
The index was the top gaining sector index in the configured sector universe on a relative basis, despite its marginal absolute decline for the day.
Breadth remained tilted lower: 6 of 20 tracked stocks advanced while 14 declined; there were no unchanged stocks.
Mankind Pharma, Torrent Pharmaceuticals and Divi's Laboratories led the gainers, while JB Chemicals & Pharmaceuticals, Aurobindo Pharma and Alkem Laboratories were among the key laggards. Watch whether the next session brings broader participation.

Closing Bell, 2 September 2026:nifty pharma today presented a relatively resilient finish within the configured sector set, closing only marginally below the previous session's level. The index saw a wide enough intraday range to show active movement, but the final change was nearly flat. The figures in this end-of-session wrap are as of 2 September 2026 at 4:15:00 PM IST.

Nifty Pharma today: a near-flat close

Nifty Pharma settled at 26,780.70, compared with 26,792.65 in the previous close, a decline of 11.95 points. In percentage terms, the move was -0.04%. That modest fall placed the sector at the top of the configured sector rankings for the session because every other listed sector index recorded a larger percentage decline.

The closing level also stood above the day's opening value of 26,668.50. This describes an intraday recovery from the opening level, although the index still finished fractionally below its prior close. The day therefore combined a limited net loss with mixed stock-level outcomes rather than a uniform sector move.

Price snapshot

The index traded between a day low of 26,611.75 and a day high of 26,818.50, a range of 206.75 points. Its close of 26,780.70 was 37.80 points below the session high and 168.95 points above the session low. It also closed 112.20 points above the opening level.

These levels frame the day’s price action: Nifty Pharma moved higher from its intraday low and retained much of that recovery into the close, while remaining just below the previous close. For readers tracking nifty pharma today, the key factual reference points are 26,780.70 at close, 26,792.65 at the previous close, 26,818.50 at the high and 26,611.75 at the low.

Sector ranking

Nifty Pharma ranked first among the configured sector indices selected for this update on 2 September. This relative position reflects its -0.04% movement, which was milder than Nifty Metal’s -0.25%, Nifty Bank’s -0.41%, Nifty FMCG’s -0.47%, Nifty Financial Services’ -0.73%, Nifty Mid Select’s -1.01%, Nifty IT’s -1.25% and Nifty Auto’s -1.79%.

Being the top gaining sector index in this ranking should be read as relative session performance, not as an absolute rise in the index. Nifty Pharma’s own closing change was marginally negative. The ranking nevertheless highlights that pharma held up better than the other configured sector indices in this comparison.

Constituent breadth

The sector’s breadth was uneven. Of the 20 display-safe stocks tracked within Nifty Pharma, 6 advanced and 14 declined, with none unchanged. The advance-decline ratio was 0.43, meaning decliners outnumbered advancers by more than two to one.

This breadth reading differs from the nearly flat index outcome. A smaller group of gainers coexisted with a larger number of declining stocks, while the index itself finished only 0.04% lower. The data therefore indicates mixed participation rather than broad-based strength across the basket.

Heavyweights versus broader participation

Among the named heavyweight stocks, Sun Pharmaceutical Industries rose 0.14% to ₹1,931.70, Divi's Laboratories gained 0.60% to ₹9,220, and Torrent Pharmaceuticals advanced 0.94% to ₹5,012. Cipla declined 0.72% to ₹1,412.80, while Dr. Reddy's Laboratories fell 1.24% to ₹1,156.50.

The named most-active list included Sun Pharmaceutical Industries, Divi's Laboratories, Torrent Pharmaceuticals, Cipla and Dr. Reddy's Laboratories. Their mixed price moves mirror the broader breadth picture: positive moves in some prominent names were offset by declines in others.

Key Nifty Pharma stocks

Stock	Move	Why it matters
Mankind Pharma	+1.49% to ₹2,391.50	Top percentage gainer in the sector basket; closed at its day high.
Torrent Pharmaceuticals	+0.94% to ₹5,012	Named heavyweight that finished at its day high.
Divi's Laboratories	+0.60% to ₹9,220	Positive heavyweight move while the index ended marginally lower.
JB Chemicals & Pharmaceuticals	-3.87% to ₹2,408.90	Largest percentage decline among the supplied sector stocks.
Aurobindo Pharma	-2.09% to ₹1,648.20	One of the sharper declines in the basket.
Alkem Laboratories	-1.70% to ₹5,210	Its decline was among the notable negative moves.

Biggest positive movers

Mankind Pharma was the strongest percentage gainer, adding 1.49% and closing at ₹2,391.50, which was also its day high. Torrent Pharmaceuticals gained 0.94% to ₹5,012, also at its day high. Divi's Laboratories rose 0.60% to ₹9,220 after trading as high as ₹9,299.

Other positive finishers included Sun Pharmaceutical Industries, up 0.14% to ₹1,931.70, and Laurus Labs, up 0.13% to ₹1,864. Lupin added 0.10% to ₹2,155.20 and also ended at its day high. These gains provided positive counterweights within a sector where declining names remained more numerous.

Biggest negative movers

JB Chemicals & Pharmaceuticals declined 3.87% to ₹2,408.90, after trading between ₹2,380 and ₹2,525.50. Aurobindo Pharma fell 2.09% to ₹1,648.20, while Alkem Laboratories lost 1.70% to ₹5,210.

Ipca Laboratories was down 1.56% to ₹1,956.50 and Dr. Reddy's Laboratories fell 1.24% to ₹1,156.50, its day low. Zydus Lifesciences declined 1.16% to ₹1,154.20. These losses explain why the sector breadth remained negative despite the index’s limited closing decline.

Stocks to watch next session

Mankind Pharma: It closed at ₹2,391.50, its day high, after a 1.49% gain.
Torrent Pharmaceuticals: It gained 0.94% and finished at ₹5,012, matching its day high.
Divi's Laboratories: It closed 0.60% higher at ₹9,220 after reaching ₹9,299.
JB Chemicals & Pharmaceuticals: It was the largest percentage decliner, ending 3.87% lower at ₹2,408.90.
Aurobindo Pharma: It ended 2.09% lower at ₹1,648.20 after touching a low of ₹1,639.60.
Dr. Reddy's Laboratories: It closed at its day low of ₹1,156.50, down 1.24%.

The constructive case

The constructive evidence is relative and price-based. Nifty Pharma’s -0.04% move was the mildest decline among the configured sector indices, placing it first in the session’s relative sector ranking. The index also closed above its opening level and well above its day low.

At the stock level, Mankind Pharma, Torrent Pharmaceuticals, Divi's Laboratories, Sun Pharmaceutical Industries, Laurus Labs and Lupin closed higher. Gains in several named heavyweight stocks, notably Torrent Pharmaceuticals and Divi's Laboratories, coincided with the index’s near-flat finish.

The cautious case

The breadth data remained negative, with 14 decliners against 6 advancers. The index ended below both the previous close and the day high. JB Chemicals & Pharmaceuticals, Aurobindo Pharma, Alkem Laboratories, Ipca Laboratories and Dr. Reddy's Laboratories recorded notable losses.

Accordingly, the sector’s relative outperformance within the configured indices did not translate into broad-based gains among its tracked stocks. The next session’s distribution between advancers and decliners will be important alongside the index level.

Univest Insights

The end-of-session picture for Nifty Pharma is one of relative steadiness rather than outright strength. A 0.04% decline is small in isolation, and it compared favourably with the larger declines recorded by the other configured sector indices.

Intraday action was more substantial than the closing percentage suggests. The index rose from 26,611.75 at the low to close at 26,780.70, while its high was 26,818.50. This kept the close nearer the session high than the low.

Stock-level performance was divided. Positive moves in Mankind Pharma, Torrent Pharmaceuticals and Divi's Laboratories stood alongside sharper weakness in JB Chemicals & Pharmaceuticals, Aurobindo Pharma and Alkem Laboratories. The 6-to-14 breadth split captures that contrast.

Readers can follow the broader market context through Univest Market View. For traders and investors, the key signal to watch is…

Published on 2 September 2026 at 4:15 PM IST

Frequently asked questions

How did Nifty Pharma close today?

Nifty Pharma closed at 26,780.70 on 2 September 2026, down 11.95 points or 0.04% from 26,792.65.

What were Nifty Pharma's day high and day low?

The index recorded a day high of 26,818.50 and a day low of 26,611.75.

Why was Nifty Pharma the top gaining sector index despite falling?

Its 0.04% decline was the mildest movement among the configured sector indices, giving it the top relative ranking for the session.

What was the breadth in Nifty Pharma today?

Six stocks advanced and 14 declined among 20 tracked display-safe stocks. No stocks were unchanged.

Which stocks gained the most in Nifty Pharma?

Mankind Pharma gained 1.49%, Torrent Pharmaceuticals rose 0.94%, and Divi's Laboratories added 0.60%.

Which stocks declined the most in Nifty Pharma?

JB Chemicals & Pharmaceuticals fell 3.87%, Aurobindo Pharma declined 2.09%, and Alkem Laboratories was down 1.70%.

Disclaimer

Investments in securities markets are subject to market risks. Read all related documents carefully before investing. This sector-index update is for informational and educational purposes only and is not personalized investment advice or a recommendation to buy, sell, or hold any security.